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regulation of LFA-1 and VLA-4 integrin adhesive 
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ABSTRACT CD47 plays an important but incompletely understood role in the innate and 
adaptive immune responses. CD47, also called integrin-associated protein, has been demon-
strated to associate in cis with β1 and β3 integrins. Here we test the hypothesis that CD47 
regulates adhesive functions of T-cell α4β1 (VLA-4) and αLβ2 (LFA-1) in in vivo and in vitro 
models of inflammation. Intravital microscopy studies reveal that CD47−/− Th1 cells exhibit 
reduced interactions with wild-type (WT) inflamed cremaster muscle microvessels. Similarly, 
murine CD47−/− Th1 cells, as compared with WT, showed defects in adhesion and transmigra-
tion across tumor necrosis factor-α (TNF-α)–activated murine endothelium and in adhesion to 
immobilized intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion protein 1 
(VCAM-1) under flow conditions. Human Jurkat T-cells lacking CD47 also showed reduced 
adhesion to TNF-α–activated endothelium and ICAM-1 and VCAM-1. In cis interactions be-
tween Jurkat T-cell β2 integrins and CD47 were detected by fluorescence lifetime imaging 
microscopy. Unexpectedly, Jurkat CD47 null cells exhibited a striking defect in β1 and β2 
integrin activation in response to Mn2+ or Mg2+/ethylene glycol tetraacetic acid treatment. 
Our results demonstrate that CD47 associates with β2 integrins and is necessary to induce 
high-affinity conformations of LFA-1 and VLA-4 that recognize their endothelial cell ligands 
and support leukocyte adhesion and transendothelial migration.
INTRODUCTION
CD47 is a ubiquitously expressed 50-kDa transmembrane glycopro-
tein with a single immunoglobulin G (Ig)-like domain, a hydrophobic, 
five transmembrane-spanning segment, and a short hydrophobic 
cytoplasmic tail (Brown et al., 1990). CD47 has also been called inte-
grin-associated protein because of its demonstrated ability to inter-
act in cis with αvβ3, αIIbβ3, α2β1, and α4β1 integrins in nonleukocyte 
cell types (reviewed in Brown and Frazier, 2001). CD47 also interacts 
in trans with signal regulatory proteins (SIRPs) and thrombospondin 
(TSP; reviewed in Barclay, 2009). CD47 is involved in a broad range 
of important physiological processes, including leukocyte phagocy-
tosis, recognition of “self,” immune cell homeostasis, cell migration 
and regulation, leukocyte transendothelial and transepithelial 
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adhesion defect is not explained by reduced expression of adhesion 
molecules in CD47−/− mice because WT and CD47−/− Th1 cells 
express identical levels of LFA-1, VLA-4, and P-selectin glycoprotein 
ligand-1 (PSGL-1) and similar levels of intracellular IFN-γ, the Th1 
signature cytokine (Figure 1, C and D). We routinely verified the 
absence of CD47 expression in CD47−/− T-cells (Figure 1C).
CD47 regulates Th1 effector cell adhesion 
and transmigration in vitro
To further delineate the adhesion defect in CD47−/− T-cells, we mon-
itored adhesion and TEM of WT and CD47−/− Th1 cells on WT and 
CD47−/− murine heart endothelial cell (MHEC) monolayers by live-
cell videomicroscopy in an in vitro flow model (Alcaide et al., 2012). 
WT Th1 cells arrested, and subsequently ∼30% of adherent cells 
transmigrated across TNF-α–activated WT monolayers (Figure 2, A 
and B). As we would predict from the in vivo studies, CD47−/− Th1 
cells exhibited reduced adhesion and TEM across WT endothelium 
compared with WT Th1 cells. CD47−/− T-cells also showed reduced 
adhesion and TEM across CD47−/− MHEC monolayers. Of interest, 
WT Th1 cells also exhibited significantly reduced adhesion and 
TEM across CD47−/− MHECs, indicating that endothelial cell CD47 
also plays a role in TEM. Analysis of MHECs isolated from CD47−/− 
and WT mice showed essentially identical levels of surface-ex-
pressed PECAM-1 and ICAM-2 at baseline and similar levels of 
ICAM-1, VCAM-1, and E-selectin expression at baseline and after 
4 h of TNF-α treatment (Figure 2C). These in vivo and in vitro stud-
ies indicate that expression of CD47 in both T-cells and endothe-
lium is required for normal Th1 cell adhesion and TEM of TNF-α–
inflamed endothelium. Here we focus on the role that CD47 
expressed on T-cells plays in leukocyte recruitment.
CD47 regulates Th1 cell adhesion to immobilized ICAM-1 
and VCAM-1
CD47 associates with and regulates the adhesive functions of retic-
ulocyte-expressed α4β1 integrins (Brittain et al., 2004), but no study 
examined whether CD47 regulates αLβ2 (LFA-1) integrin adhesive 
interactions with its endothelial ligand ICAM-1. We therefore stud-
ied the adhesion of WT and CD47−/− Th1 cells to ICAM-1-Fc coim-
mobilized with CXCL12 (SDF-1α) chemokine under flow conditions 
(Alcaide et al., 2012). WT Th1 cells arrested on ICAM-1, whereas 
CD47−/− Th1 cells showed a significant reduction in arrest (Figure 
3A). Of note, the greatest relative reduction occurred at the highest 
shear stress level examined. This assay was repeated using immobi-
lized VCAM-1-Fc molecules without chemokine because T-cells con-
stitutively express VLA-4 integrins capable of binding VCAM-1 un-
der flow conditions (Chen et al., 1999). A significant defect in 
CD47−/− Th1 cell arrest to VCAM-1 was observed at high shear stress 
levels but not at the lowest shear stress tested (Figure 3B). There 
were no differences between WT and CD47−/− Th1 cell accumulation 
on immobilized E-selectin, suggesting that induction of Th1 selectin 
ligand expression was not affected (Figure 3C). Taken together, the 
data suggest that CD47 in Th1 cells plays an important role in the 
function of LFA-1 and VLA-4 integrins required for adhesion to their 
endothelial cell ligands.
CD47 does not regulate LFA-1 adhesion-strengthening 
ICAM-1
Because CD47−/− Th1 cells showed a larger defect in adhesion to 
ICAM-1 compared with VCAM-1, we focused on LFA-1 and de-
termined whether adhesion strengthening to ICAM-1, termed 
avidity regulation, was affected. Accordingly, we compared the 
ability of adherent WT and CD47−/− Th1 cells to resist detachment 
migration, platelet adhesion and activation, and nitric oxide signaling 
(Brown and Frazier, 2001; Isenberg et al., 2008).
Previous studies in CD47−/− mice established that CD47 plays a 
role in neutrophil emigration in a bacteria-induced peritonitis model 
(Lindberg et al., 1996), a lipopolysaccharide-induced, neutrophil-
mediated acute lung injury and a bacterial pneumonia model (Su 
et al., 2008), and in vitro models of human neutrophil and monocyte 
transmigration across endothelium (Cooper et al., 1995; de Vries 
et al., 2002) and epithelium (Parkos et al., 1996). CD47 also was 
implicated in dendritic cell recruitment in a trinitrobenzenesulfonic 
acid–induced colitis model of hapten-stimulated inflammation 
(Fortin et al., 2009) and T-cell activation in the myelin oligodendro-
cyte glycoprotein–induced experimental autoimmune encephalo-
myelitis model (Han et al., 2012). We recently reported that human 
endothelial CD47 interacts with T-cell–expressed SIRPγ during T-cell 
transendothelial migration (TEM) under flow conditions in vitro 
(Stefanidakis et al., 2008). We also reported that CD47−/− mice 
showed reduced recruitment of blood T-cells, neutrophils, and 
monocytes in a dermal air pouch model of tumor necrosis factor-α 
(TNF-α)–induced inflammation and both endothelial- and leuko-
cyte-expressed CD47s were required (Azcutia et al., 2012). On the 
basis of our findings that T-cells show significantly reduced recruit-
ment in murine models in vivo and in human and murine in vitro 
models of inflammation, we investigated whether the defect is re-
lated to loss of CD47-dependent integrin adhesive functions.
The results of our study indicate that CD47 associates with 
T-cell β2 integrins as assessed by fluorescence lifetime imaging 
microscopy (FLIM) and CD47 is necessary for induction of VLA-4 
and LFA-1 integrin high-affinity conformations that bind to their 
ligands vascular cell adhesion protein 1 (VCAM-1) and intercellular 
adhesion molecule 1 (ICAM-1), respectively. Our results suggest 
that in cis CD47–integrin associations, together with the previously 
reported in trans CD47–SIRP interactions (Stefanidakis et al., 2008), 
are important for both adhesion and transmigration across the vas-
cular endothelium in in vivo and in vitro models of inflammation.
RESULTS
CD47−/− Th1 cells exhibit defective adhesive interactions 
with TNF-α–activated endothelium in the murine cremaster 
microvasculature
To evaluate the role of CD47 in leukocyte adhesive interactions with 
endothelium in vivo, we performed intravital microscopy studies in 
the murine cremaster microcirculation after intrascrotal injection of 
TNF as described earlier (Alcaide et al., 2012). Equal numbers of in 
vitro–generated wild-type (WT) and CD47−/− Th1 effector cells, each 
labeled with a different color fluorescent dye, were coinjected into 
WT recipient animals to enable comparison of WT and CD47−/− Th1 
cells in the same postcapillary venules. The microvessel parameters 
for WT and CD47−/− mice are listed in Table 1. The behavior of trans-
ferred Th1 cells was monitored for 2–5 min postinjection. CD47−/− 
Th1 cells exhibited significantly reduced tethering adhesive interac-
tions relative to WT Th1 cells (Figure 1A). The reciprocal experiment 
of simultaneous injection of differentially fluorescent-labeled WT and 
CD47−/− Th1 cells into CD47−/− recipient mice revealed that CD47−/− 
Th1 cells interacted less than did WT cells. Tethered Th1 cells be-
come stably bound to the inflamed vessel wall for more than three 
consecutive video frames (∼2 s). Few, if any, of the transferred T-cells 
arrest for more than several seconds. These results indicate expres-
sion of CD47 in T-cells is required for optimal Th1 effector cell adhe-
sive interactions in this model. There was no difference between WT 
and CD47−/− T-cells in the rolling velocities, indicating that CD47 was 
not involved in Th1 cell rolling on inflamed venules (Figure 1B). This 
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difference in the rate of cell detachment 
was detected upon applying the shear 
flow regime (Figure 3D). This finding dem-
onstrates that CD47 is not necessary for 
postadhesion LFA-1 adhesion strengthen-
ing to ICAM-1.
CD47-null human T-cells phenocopy 
the defects in murine CD47−/− Th1-cell 
adhesion
An earlier study reported that human Jur-
kat T-cell clone JINB8 lacking CD47 
(CD47−) showed reduced binding to a 
TNF-α–stimulated human endothelial-like 
cell line as compared with the parental 
clone expressing CD47 (CD47+; Ticchioni 
et al., 2001). Accordingly, we evaluated 
their adhesion to TNF-α–activated human 
umbilical vein endothelial cells (HUVECs) 
and immobilized ICAM-1 and VCAM-1. 
Both Jurkat clones express similar surface 
levels of LFA-1 and VLA-4 α-subunits 
and the respective common β2 and β1 
integrin subunits (Figure 4A). CD47+ 
Jurkat cells showed significantly greater 
adhesion to 4-h TNF-α–activated HUVEC 
monolayers than did CD47− cells at each 
shear stress tested (Figure 4B). Of inter-
est, the dominant integrin responsible for 
T-cell adhesion was VLA-4 as determined 
by function-blocking monoclonal anti-
body (mAb) studies (Figure 4C), which is 
consistent with earlier studies (Chen et al., 
1999; Ticchioni et al., 2001). Blocking 
LFA-1 on CD47+ Jurkat cells reduced 
adhesion to similar levels as unblocked 
CD47− Jurkat cells. Blockade of LFA-1 on 
CD47− Jurkat cells did not further reduce 
adhesion to HUVECs. The lesser role of 
LFA-1 in Jurkat T-cell adhesion to HUVECs 
is likely the reason that Jurkat CD47− T-cell 
adhesion is not reduced to a greater level, 
as we would have predicted (Figure 4C).
We next evaluated Jurkat T-cell adhe-
sion to immobilized ICAM-1, VCAM-1, and 
E-selectin under the same conditions as in 
Figure 3. CD47− T-cells showed signifi-
cantly reduced stable arrest to both 
ICAM-1 and VCAM-1 compared with 
CD47+ cells (Figure 5, A and B). The de-
fects in arrest were most pronounced on ICAM-1 compared with 
VCAM-1, whereas there was no defect in adhesion to E-selectin 
(Figure 5C). As a control, we created stably transfected CD47− 
Jurkat cells expressing full-length CD47 tagged with green fluo-
rescent protein (GFP; CD47+GFP) or GFP alone (CD47−GFPcont). 
from ICAM-1 immobilized with CXCL12 under increasing flow 
rates (Sircar et al., 2007). Whereas the number of CD47−/− Th1 
cells initially bound under the lowest shear flow setting was 31% 
lower than with WT (264 ± 86 cells/mm2 for WT adhesion vs. 
182 ± 60 cells/mm2 for CD47−/−, p < 0.05, Student’s t test), no 
FIGURE 1: Adhesive interactions of Th1 effector cells with inflamed murine cremaster muscle 
microcirculation. (A) Impaired interaction of CD47−/− Th1 effector cells with TNFα-activated 
microvessels of the cremaster muscle. Tethered cells are defined as labeled Th1 cells that are 
stably bound to the inflamed vessel wall for more than three consecutive video frames (∼2 s). 
Data are means ± SEM from five WT and CD47−/− recipient mice (13 vessels in WT and 7 vessels 
in CD47−/− mice). *p < 0.05 vs. WT Th1 in CD47−/− recipient; **p < 0.01 vs. WT Th1 in WT 
recipient (Student’s t test). (B) Rolling Th1 cells are defined as T-cells that interact with the vessel 
below Vcrit. Th1 cell rolling velocities were determined by measuring the length of time required 
to travel 200 μm. Velocities from three independent preparations of Th1 cells were analyzed in 
vessels from WT or CD47−/− mice. Tethered and rolling T-cells were identified in videos using 
Imaris software (Bitplane, Zurich, Switzerland). (C) WT and CD47−/− CD4+ Th1 effector cells have 
essentially the same surface expression levels of LFA-1, VLA-4, and PSGL-1. (D) Intracellular 
staining shows that IFN-γ production is similar in polarized WT (66% positive) and CD47−/− 
(68% positive) Th1 cells.
Genotype Number of mice Number of vessels Vessel diameter (μm) Wall shear rate (s−1) Vcrit (μm/s)
WT 5 11 36 ± 2 844 ± 73 622 ± 52
CD47−/− 4 5 43 ± 2 706 ± 145 533 ± 109
TABLE 1: Microvessel parameters.
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CD47 regulates β1 and β2 high-affinity 
conformations in response to Mn2+ or 
Mg2+/ethylene glycol tetraacetic acid
Integrin affinity regulation was evaluated on 
Jurkat CD47− and CD47+ cells by reporter 
mAbs that detect activated conformations 
of β1 and β2 integrins. KIM127 mAb detects 
and stabilizes an extended and closed con-
formation of β2 integrins (intermediate affin-
ity), and mAb 24 recognizes an extended 
and open “active” conformation of β2 inte-
grins (high affinity; (Salas et al., 2004). Jurkat 
T-cells express predominantly LFA-1 (αLβ2) 
and not the other α-subunit chains that as-
sociate with β2 integrins, and hence these 
mAbs to β2 integrins detect primarily the 
intermediate- and high-affinity conforma-
tions of LFA-1 (Salas et al., 2004). HUTS21 
detects and stabilizes activated β1 integrins 
(Luque et al., 1996), and we showed previ-
ously that expression of this epitope corre-
lated with robust adhesion of human mem-
ory T-cells to VCAM-1 (Lim et al., 2000). As 
expected, incubation of CD47+ T-cells with 
Mn2+ or Mg2+/ethylene glycol tetraacetic 
acid (EGTA), global activators of integrins, 
triggered robust expression of both inter-
mediate- and high-affinity LFA-1 (Figure 6, A 
and B). In contrast, CD47− T-cells showed a 
significantly reduced expression of interme-
diate- and high-affinity conformations of 
LFA-1 in response to Mn2+ or Mg2+/EGTA. It 
is unlikely that this assay did not detect tran-
sient LFA-1 activation because the mAbs 
stabilize the active conformation and were 
present throughout the assay. In addition, 
failure to detect mAb expression was not 
due to a change (loss) in total surface ex-
pression of β1 or β2 integrins upon expo-
sure to Mn2+ or Mg2+/EGTA (Figure 6C). 
CD47− T-cells also showed reduced induc-
tion of high-affinity β1 integrins versus 
CD47+ T-cells after treatment with Mn2+ or 
Mg2+/EGTA buffers (Figure 6D). Consistent 
with the failure of Mn2+ or Mg2+/EGTA treat-
ments to induce intermediate- and high-af-
finity LFA-1 conformations in the absence of 
CD47, CD47− T-cells exhibited little binding 
of soluble ICAM-1-Fc versus CD47+ T-cells 
(Figure 6E). In addition, treatment of CD47− 
cells with Mn2+ did not restore binding comparable to CD47+ T-cell 
adhesion to either immobilized ICAM-1 or VCAM-1 under flow 
(Supplemental Figure S1, A and B). Taken together, the results indi-
cate that CD47 expression is required for expression of intermedi-
ate- and high-affinity conformations of LFA-1 and for binding soluble 
ICAM-1, as well as for induction of activated β1 integrins.
To determine whether β2 integrins in CD47− cells could be acti-
vated when extracted from the membrane milieu of CD47− Jurkat 
T-cells, we examined the effect of 1.0 mM Mn2+ on β2 integrins in 
the soluble phase. When detergent lysates of CD47+ and CD47− 
T-cells were incubated in the presence of Mn2+ and mAb24 to 
immunoprecipitate activated β2 integrins, an equal and robust 
The level of CD47 expression was similar to that for the parental 
clone (data not shown) and restored arrest to ICAM-1 to a 
level similar to that for the parent clone, whereas CD47−GFP-
cont cell adhesion did not improve (Figure 5D). Finally, we ex-
amined the adhesion-strengthening capability of CD47+ and 
CD47− Jurkat T-cells, using a detachment assay. CD47− Jurkat 
T-cells also exhibited 35% reduction in initial binding under the 
lowest shear stress conditions (211 ± 24 cells/mm2 for CD47+ 
adhesion vs. 137 ± 24 cells/mm2 for CD47−; p < 0.05) but no 
defect in the rate of detachment versus CD47+ cells (Figure 5E), 
which is consistent with the behavior of murine CD47−/− Th1 cells 
(Figure 3D).
FIGURE 2: Th1 effector T-cell interactions with TNF-α–activated murine endothelium in an in 
vitro flow chamber. (A) The numbers of accumulated and (B) transmigrated T-cells in the videos 
were quantified by ImageJ software (National Institutes of Health, Bethesda, MD). Data are 
mean ± SEM. *p ≤ 0.05 and **p ≤0.01 vs. WT Th1 cell on WT MHEC. #p ≤ 0.05 are WT Th1 vs. 
CD47−/− on CD47−/− MHEC (Student’s t test), n = 3 separate experiments. (C) MHECs were 
treated with medium or medium containing murine TNF-α (100 ng/ml) for 4 h, and CD47, 
VCAM-1, ICAM-1, E-selectin, ICAM-2, and PECAM-1 expression levels were detected by 
unlabeled primary mAb followed by staining with a PE-labeled goat anti-rat secondary mAb. 
Cell fluorescence was determined by FACSCalibur flow cytometry (BD, Franklin Lakes, NJ). 
Representative histograms of surface expression of molecules are shown from 10 separate 
experiments.
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β2 integrin and CD47, and the a1 value indi-
cates that 31.7 ± 4.1% of β2 integrin mole-
cules interact with CD47 on the cellular 
membrane of Jurkat T-cells (Table 2). For 
comparison purposes the noninteracting 
molecules β2 integrin and PSGL-1 were 
costained as donor and acceptor molecules, 
respectively. A decrease of τ1 was found 
when PSGL-1 was used as acceptor, but the 
interacting fraction was only 13.3 ± 1.5% 
and approached the lower levels of sensitiv-
ity. Furthermore, the τm of the donor was 
unchanged in the presence of the acceptor, 
indicating that β2 integrin and PSGL-1 were 
not in sufficient proximity to support a physi-
cal interaction (Supplemental Table S1 and 
Supplemental Figure S2A). As a positive 
control a decrease in τ1 was observed be-
tween LFA-1 α-chain (αL integrin) and the 
common β2 chain (Supplemental Table S1 
and Supplemental Figure 2A). Representa-
tive histograms illustrate the τm of the donor 
β2 integrin in the different conditions (Sup-
plemental Figure S3, A–F). These results 
support a direct association of CD47 with β2 
integrins.
We next asked whether the CD47–β2 in-
tegrin association was altered upon incuba-
tion of T-cells with Mg2+/EGTA–containing 
medium, using the same donor and accep-
tor antibodies. Of interest, there was no 
change in τ1 (and τm) for β2 integrin–CD47, 
still indicating a close association between 
β2 integrin and CD47. The a1 values, how-
ever, indicate that significantly fewer β2 in-
tegrin molecules interact with CD47 (Table 2). This decrease in as-
sociation was not due to a change (loss) in total surface expression 
of β1 or β2 integrins upon exposure to Mn2+ or Mg2+/EGTA (Figure 
6C). We next explored whether the extended or fully activated β2 
integrin conformations interact with CD47 by staining cells with 
mAb 24 and KIM127 incubated in medium containing Mg2+/EGTA 
or medium alone. Under conditions of medium with Mg2+/EGTA or 
medium alone, we were unable to detect a signal above back-
ground for the extended conformation (KIM127). Although the sig-
nal for the fully activated β2 integrin (mAb 24) was also too low to 
detect in medium alone, the signal was clearly detected in cells in-
cubated in medium containing Mg2+/EGTA. Reduced τ1 (and τm) for 
β2 integrin–CD47 indicates close association between activated β2 
integrins and CD47, and the a1 value indicates that 28 ± 1% of acti-
vated β2 integrin molecules interact with CD47 on the cellular 
membrane of Jurkat T-cells (Table 3). These data indicate that the 
fully activated β2 integrins do interact with CD47, but the results do 
not distinguish whether the fraction of fully activated integrins as-
sociated with CD47 increases or decreases upon cation-induced 
integrin activation.
DISCUSSION
CD47 associates with and regulates α4β1 integrins in reticulocytes 
(Brittain et al., 2004). On the basis of this report and our findings that 
mouse T-cell recruitment requires CD47 expression in a dermal air 
pouch model of inflammation (Azcutia et al., 2012), we used mole-
cular imaging analysis, in vitro flow chamber adhesion assays, and in 
signal was detected in the absence and presence of CD47 (Figure 
6F, lanes 3 and 6). mAb 24 did not immunoprecipitate β2 integrins 
in either cell type in the absence of Mn2+ (lanes 2 and 5). As a con-
trol, immunoprecipitation with mAb TS1/18, which recognizes all 
conformations of β2 integrin, is shown in lanes 1 and 4. These data 
indicate that CD47 is required for full activation of β2 integrins in the 
plasma membrane milieu of human T-cells but not with detergent-
solubilized β2 integrins.
CD47 interacts with β2 integrin
Prior studies reported that VLA-4 coimmunoprecipitated with CD47 
in blood reticulocytes from sickle cell patients (Brittain et al., 2004). 
To evaluate whether CD47 associates with β2 integrins in T-cells, we 
applied fluorescence lifetime imaging microscopy (FLIM), a quanti-
tative method for determining Förster resonance energy transfer 
(FRET; Table 2 and Figure 7A), to study whether β2 integrin and 
CD47 are sufficiently close to imply a physical interaction. Epifluo-
rescence images were captured as quality control of the staining 
(Figure 7B). The lifetime of the donor molecule (τ1; picoseconds), in 
this case β2 integrin, labeled with Alexa Fluor 488–con jugated sec-
ondary antibody was determined first in the absence of an acceptor 
fluorophore (Table 2 and Figure 7A, donor only). FRET between the 
donor fluorophore (β2 integrin) and acceptor (CD47 directly labeled 
with Alexa Fluor 594) was defined by the life time of interacting mol-
ecules (τ1), with a1 (in percent) defining the frac tion of interacting 
molecules. The significant decrease of τ1 (and also the mean life-
time, τm) for β2 integrin–CD47 indicates a close association between 
FIGURE 3: CD47−/− Th1 cells have impaired adhesion to immobilized ICAM-1 and VCAM-1 but 
not E-selectin in an in vitro flow chamber model. WT and CD47−/− Th1 cells were drawn across 
immobilized ICAM-1-Fc (A), VCAM-1-Fc (B), and E-selectin-Fc chimeric proteins (C) at the shear 
stress levels indicated, and cell adhesion was determined as detailed in Materials and Methods. 
Data are mean ± SEM, n = 3. *p ≤ 0.05, **p ≤ 0.01 (Student’s t test). (D) Shear flow–mediated 
detachment of Th1 cells prebound to immobilized ICAM-1 + CXCL12 is not altered in CD47−/− 
Th1 cells. Data are mean ± SEM, n = 3 separate experiments.
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examined previously (Ticchioni et al., 2001), 
using the same Jurkat T-cell lines used here. 
These authors reported that CD47− Jurkat 
T-cells had reduced adhesion to TNF-acti-
vated endothelium and to immobilized 
VCAM-1. Our present data extend this find-
ing to include a striking defect in LFA-1 ad-
hesive function.
We also performed detachment assays 
to quantify LFA-1 adhesion strengthening to 
ICAM-1 in CD47− cells. Adhesion strength-
ening occurs after integrin activation and 
initial ligand binding and involves avidity 
regulation, defined as clustering or in-
creased mobility of integrins in the plasma 
membrane of adherent cells (Kim et al., 
2004). In contrast to the defects in arrest, 
the assay revealed no differences in detach-
ment of adherent T-cells that lacked CD47. 
This suggests that the absence of CD47 af-
fects affinity regulation of LFA-1 but not 
avidity regulation.
CD47 is required for LFA-1 and VLA-4 
high-affinity conformation expression
LFA-1 is predicted to assume at least three 
distinct conformational states: a bent struc-
ture with low affinity for ligand, an extended 
and closed headpiece structure with inter-
mediate affinity, and an extended and open 
headpiece structure with high affinity (Hogg 
et al., 2011; Lefort et al., 2012). Recent stud-
ies report that the high-affinity LFA-1 confor-
mation is required for T-cell arrest and adhe-
sion to ICAM-1 expressed by endothelium 
or binding soluble ICAM-1 (Constantin et al., 
2000; Salas et al., 2004; Shamri et al., 2005; 
Smith et al., 2005). Mn2+ or Mg2+/EGTA 
treatments bypass inside-out signaling and trigger high-affinity β1 
and β2 conformations and rapid ligand binding (Shimaoka et al., 
2002). Indeed, CD47+ T-cells exhibit a robust response to these stim-
uli and avidly bind integrin activation reporter mAbs KIM127, 24, 
and HUTS21. A notable and unanticipated result was that high-affin-
ity conformations in β2 integrins, and to a lesser extent β1 integrins, 
were only modestly induced by Mn2+ or Mg2+/EGTA in CD47− Jurkat 
T-cells. In addition, Mn2+ treatment of CD47− cells failed to restore 
their adhesive function to immobilized ICAM-1 and VCAM-1. 
Because we observed more-severe defects in LFA-1 versus VLA-4 
function in CD47− T-cells, we chose to study a possible novel CD47 
regulation of LFA-1 in more detail. In a second readout of LFA-1 ac-
tivation, soluble ICAM-1 binding was also dramatically reduced in 
CD47− T-cells. Our results suggest that CD47 directly or indirectly 
facilitates and/or stabilizes activated forms of LFA-1. To our knowl-
edge this is the first report to demonstrate in leukocytes a require-
ment for a second transmembrane protein to achieve high-affinity 
LFA-1 conformations. This effect of CD47 on LFA-1 activation oc-
curred only in intact cell membrane microenvironment because β2 
integrins solubilized from CD47+ or CD47− cells could be activated 
by Mn2+. Further studies are necessary to identify the molecular 
mechanism of CD47 interactions with and regulation of leukocyte β 
and β2 integrin binding affinity. Previous studies, however, shed 
some light on this topic. In VLA-4–expressing reticulocytes isolated 
vivo studies to investigate whether the defect in T-cell recruitment 
was related to impaired β1 and β2 adhesive functions in the ab-
sence of CD47. Indeed, our key observation is that CD47 is neces-
sary to induce high-affinity conformations of LFA-1 and VLA-4 in 
T-cells.
CD47 regulates LFA-1 and VLA-4 adhesive functions under 
shear flow conditions
Effector T-cell arrest, migration, and transendothelial migration re-
quire VLA-4 and LFA-1 integrin activation and binding to their en-
dothelial ligands VCAM-1 and ICAM-1. Our present data show that 
murine CD47−/− Th1 effector cells, as compared with WT, have re-
duced adhesive interactions with inflamed cremaster microvessels 
and reduced adhesion and transmigration across TNF-α–activated 
endothelium. These defects can be explained by our data showing 
that CD47−/− Th1 cells have reduced adhesion to immobilized 
VCAM-1 and ICAM-1 but not E-selectin. This result implies that 
CD47−/− Th1 cells have impaired β1 and β2 integrin adhesive func-
tions. Accordingly, the use of human Jurkat T-cells that lack CD47 
showed striking defects in integrin-dependent adhesion identical to 
murine CD47−/− Th1 cells. Thus we conclude that CD47 expression 
plays a critical role in LFA-1 and VLA-4 binding to ICAM-1 and 
VCAM-1 under flow conditions in vivo and in vitro. The role of CD47 
in regulation of VLA-4 adhesion under shear flow conditions was 
FIGURE 4: Human Jurkat T-cell integrin expression and adhesion to HUVEC monolayers in an in 
vitro flow model. (A) Jurkat CD47+ clone E6 and CD47− (null) clone JINB8 express similar levels 
of LFA-1 and VLA-4 integrins. Data are representative of three separate experiments. (B) Jurkat 
CD47− T-cells were drawn across the TNF-α–activated HUVECs at various estimated shear stress 
levels as described in Materials and Methods. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 for indicated 
comparisons (Student’s t test). (C) Both CD47+ and CD47− Jurkat T-cell adhesion (under shear 
stress of 0.76 dynes/cm2) to TNF-α–activated HUVECs is strongly dependent on VLA-4 integrins. 
The reduction in adhesion in CD47+ cells with blockade of LFA-1 is not observed in CD47− cells, 
suggesting that LFA-1–dependent adhesion requires CD47. Data are mean ± SEM of three 
experiments. *p ≤ 0.05, **p ≤ 0.01 vs. CD47+ with no mAb in medium; #p < 0.05, media CD47− 
vs. anti-VLA-4 mAb–treated CD47− cells (Student’s t test).
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Jurkat T− cells (Table 2). FLIM studies per-
formed on T-cells in medium that activates 
β2 integrins suggest that β2 integrins remain 
associated with CD47 and that the percent-
age of interacting molecules was signifi-
cantly reduced. Parallel studies with mAb 
24, which detects fully activated β2 integ-
rins, confirm that activated integrins associ-
ate with CD47; however, comparison of the 
fraction of activated β2 integrins that associ-
ate with CD47 at rest and upon activation 
could not be determined. Further studies 
are necessary to explore the spatial and 
temporal interactions between CD47 and 
β1 and β2 integrins during leukocyte adhe-
sive interactions with VCAM-1 and ICAM-1 
and with activated endothelium. We specu-
late that CD47 plays a role in regulating 
high-affinity conformations of integrins in 
other leukocyte types, based on our report 
that recruitment of neutrophils, CD3+ T-cells, 
and monocytes is significantly reduced in a 
dermal air pouch model in CD47−/− mice 
(Azcutia et al., 2012). It is also likely that the 
results reported here for CD47 regulation of 
LFA-1 and VLA-4 explain, in part, the re-
duced leukocyte recruitment and level of 
inflammation in CD47−/− mice reported pre-
viously (Lindberg et al., 1996; de Vries et al., 
2002; Su et al., 2008; Azcutia et al., 2012).
In summary, our results indicate that 
CD47 in cis interactions regulate LFA-1 and 
VLA-4 integrin affinity, and in turn, this pro-
cess plays a substantial role in the adhesion 
and diapedesis of T-cells in models of in-
flammation. From our present results we in-
fer the existence of a distinct and perhaps 
novel pathway that regulates T-cell recruit-
ment in vivo to sites of inflammation, and we 
identify a potential therapeutic target for the 
treatment of immune-mediated diseases.
MATERIALS AND METHODS
Materials
Recombinant human and mouse E-selectin, 
VCAM-1, and ICAM-1 Fc-chimeras were 
from R&D Systems (Minneapolis, MN). Re-
combinant mouse interleukin-2 (IL-2), IL-12, and TNF-α were pur-
chased from BioLegend (San Diego, CA). The following hybridoma 
clones were purchased from the American Type Culture Collection, 
Manassas, VA) and used as purified IgG: mAbs to β2 integrins in-
clude KIM127 (Andrew et al., 1993) and TS1/18 (Miller et al., 1986); 
TS1/22 recognizes LFA-1 (Miller et al., 1986); B6H12 and 2D3 are 
functional blocking and nonblocking, respectively, and recognize 
human CD47 (Brown et al., 1990). 13A9 recognizes a functional 
epitope in PSGL-1 (Snapp et al., 1997); mAb 24 was provided by 
Nancy Hogg (Cancer Research Institute, London, United Kingdom; 
Dransfield and Hogg, 1989); HUTS 21, LIA1/2.1, and HP2/1 were 
provided by Francisco Sanchez-Madrid (Hospital de la Princesa, 
Madrid, Spain; Lim et al., 2000); rabbit polyclonal anti-CD18 was 
described previously (Quinn et al., 2001); and mAb to mouse CD47 
(miap301) was from eBiosciences (San Diego, CA). mAb to mouse 
from sickle cell disease patients, CD47 coimmunoprecipiated with 
β1 integrins and regulated VLA-4–dependent adhesion to VCAM-1 
and TSP-1 (Brittain et al., 2004). Other reports used various CD47 
chimeric molecules expressed in Jurkat CD47− cells to demonstrate 
that only the extracellular IgV and first transmembrane domains 
of CD47 were required to restore Jurkat T-cell arrest on VCAM-1 
(Ticchioni et al., 2001). A similar strategy in a CD47− ovarian cancer 
cell line demonstrated that expression of the IgV domain linked to 
GPI was sufficient to promote clustering of αvβ3 and binding of ac-
tivation-sensing LIBS1 and LIB6 mAb (McDonald et al., 2004). Our 
FLIM-FRET analyses support a direct in cis association between 
CD47 and β2 integrins in Jurkat T-cells. The significant decrease of 
both τm and τ1 for β2 integrin–CD47 supports the conclusion of a 
close association between β2 integrin and CD47, and the a1 value 
indicates that ∼32% of β2 integrin molecules interact with CD47 in 
FIGURE 5: Jurkat CD47− (null) T-cells have impaired adhesion to immobilized ICAM-1 and 
VCAM-1 but not E-selectin under shear flow conditions. (A–C) Jurkat T-cells were drawn across 
immobilized ICAM-1 (A), VCAM-1 (B), or E-selectin (C) proteins at various shear stress levels, and 
adhesion was measured as described in Materials and Methods. (D) Transfection of CD47− 
Jurkat cells with a plasmid containing CD47 tagged with GFP (CD47 + GFP) rescued cell 
adhesion to ICAM-1. In contrast, transfection of CD47− cells with a plasmid containing only GFP 
(CD47-GFPcontrol) did not. (E) Detachment of Jurkat T-cells prebound to immobilized ICAM-1 is 
not affected by the absence of CD47. Data are means ± SEM of at least three independent 
experiments. *p ≤ 0.05, **p ≤ 0.01 (Student’s t test).
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Research Building in accordance with the 
guidelines of the Committee of Animal 
Research at the Harvard Medical School 
and the National Institutes of Health ani-
mal research guidelines.
Cells
HUVECs were isolated and passaged as 
previously described and used at passage 2 
for in vitro flow chamber assays (Stefanida-
kis et al., 2008). MHECs were prepared as 
described (Alcaide et al., 2012) from 8- to 
12-d-old animals. Murine CD4+ Th1 effec-
tor cells were derived from naive T-cells by 
CD3 and CD28 stimulation in the presence 
of IL-12 and IFN-γ polarizing conditions as 
previously described (Alcaide et al., 2012). 
The human Jurkat T-cell E6.1 clone express-
ing CD47 (TIB-152) was from the American 
Type Culture Collection, and Jurkat T-cell 
clone E6.1 lacking CD47 (JINB8) was de-
scribed previously (Ticchioni et al., 2001). 
Jurkat T-cells were maintained in RPMI-
1640 supplemented with 10% fetal bovine 
serum (FBS), antibiotics, and L-GlutaMAX.
Flow cytometry
Flow cytometry analysis of intracellular IFN-γ 
was performed to corroborate the differen-
tiation of Th1 cells and monitor expression 
of murine CD47, LFA-1, VLA-4, and PSGL-1 
and also on human Jurkat T-cells using stan-
dard immunofluorescence staining and flow 
cytometry methods.
Intravital microscopy
In vitro polarized WT and CD47−/− Th1 
cells were labeled with different fluores-
cent dyes (CFSE or Alexa 680), and then 
3 × 106 of each cell type were mixed to-
gether and coinjected retrograde using a 
femoral artery catheter into WT or CD47−/− 
recipient mice 2 h after TNF-α injection as 
described (Alcaide et al., 2012). Leuko-
cyte–endothelial adhesive interactions 
were obtained with an Olympus FV 1000 
intravital microscope (Center Valley, PA) 
equipped with a LumPlan 40×/0.8 numerical aperture (NA) water 
immersion objective and digitally recorded with an Olympus 
DP71 charge-coupled device video camera and Olympus 
FluoView 1000 imaging software. Rolling Th1 cells were identi-
fied as the visible cells passing through and transiently interact-
ing with vessel surface in a plane perpendicular to the vessel axis. 
Rolling velocities were calculated as previously detailed (Alcaide 
et al., 2012). Vcrit was calculated as described previously (Ley 
et al., 1995; Yang et al., 1999).
T-cell adhesion to immobilized Fc chimera adhesion 
molecules and MHECs under defined laminar shear flow 
conditions in vitro
T-cell adhesion and transendothelial migration and interactions with 
immobilized adhesion molecules were performed as described 
interferon (IFN)-γ, ICAM-1, ICAM-2, VCAM-1, PECAM-1, E-selectin, 
PSGL-1, LFA-1, and VLA-4 were purchased from BD PharMingen 
(San Jose, CA). Vibrant CFSE and Alexa 680 cell tracker, goat anti-
mouse and anti-rabbit Alexa Fluor 488, and goat anti-mouse and 
anti-rabbit Alexa Fluor 594 secondary antibodies were from Invitro-
gen (Carlsbad, CA). Vectashield with 4′,6-diamidino-2-phenylindole 
(DAPI) was from Vector Laboratories (Burlingame, CA).
Mice
CD47-deficient (CD47−/−) mice (C57BL/6 strain) were obtained 
from Eric Brown (Genentech, South San Francisco, CA; Lindberg 
et al., 1996). WT C57BL/6 mice (Charles River Laboratories, Wilm-
ington, MA) were used to establish a breeding colony in our facil-
ity for use as WT control animals. All mice used were bred in the 
same pathogen-free facility at Harvard Medical School New 
FIGURE 6: Mn2+ or Mg2+/EGTA fails to induce strong LFA-1 and β1 high-affinity conformation 
expression or binding of soluble ICAM-1-Fc chimera in CD47− (null) Jurkat T-cells. (A–D) Mn2+ or 
Mg2+/EGTA–induced expression of LFA-1 extended and open “activated” conformations of 
LFA-1 were detected by the reporter mAb KIM127 (A) and mAb24 (B). Results are normalized to 
isotype-matched, control nonbinding mAb. Expression of these active conformations of 
integrins by 0.5 mM Mn2+ or 10 mM Mg2+/1 mM EGTA treatments was significantly reduced in 
CD47− Jurkat T-cells. (C) Total levels of β2 and β1 integrins detected with TS1/18 and LIA1/2.1 
mAb, respectively, did not change after Mn2+ or Mg2+/EGTA stimulation. No change was 
detected in CD47 (data not shown). (D) High-affinity β1 integrins induced by Mn2+ or Mg2+/
EGTA buffer were measured by mAb HUTS21. (E) CD47− T-cells exhibited little binding of 
soluble ICAM-1 as compared with CD47+ T-cells induced by Mn2+ and Mg2+/EGTA treatments. 
Results are normalized to incubation buffer alone. Data are mean ± SEM, n = 3. *p ≤ 0.05, 
**p ≤ 0.01 (Student’s t test). (F) Mn2+ activates solubilized β2 integrins from CD47+ (lane 3) and 
CD47-null (lane 6) Jurkat T-cells. Lysates of Jurkat cells were subjected to immunoprecipitation 
with anti-β2 integrin mAb 24 (lanes 2, 3 and 5, 6) in the absence (–) or presence (+) of 1.0 mM 
Mn2+, followed by SDS–PAGE and immunoblotting with anti-β2 integrin polyclonal Ab (R&D 
Systems). Immunoprecipitation with mAb TS1/18 (lanes 1 and 4) served as a positive control to 
ensure the presence of β2 integrin in the lysate.
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Condition τ1 (ps) a1 (%) τm (ps)
β2 integrin 
(donor only)
2836 ± 11 100 ± 0 2836 ± 11
β2 integrin + 
CD47 (B6H12)
842.7 ± 137a 32 ± 4 2218 ± 136a
β2 integrin 
(donor only) + 
Mg2+/EGTA
2889 ± 21.3 100 ± 0 2889 ± 21
β2 integrin + 
CD47 (B6H12) 
+ Mg2+/EGTA
804 ± 101b# 23 ± 1c 2442 ± 50b#
Values represent mean ± SEM for n = 20 for each condition.
ap < 0.001 β2 integrin–CD47 vs. β2 integrin donor only.
bp < 0.001 β2 integrin–CD47 + Mg2+/EGTA vs. β2 integrin donor only + Mg2+/
EGTA.
cp < 0.05 β2 integrin–CD47 + Mg2+/EGTA vs. β2 integrin + CD47 unstimulated.
#n.s., β2 integrin–CD47 + Mg2+/EGTA vs. β2 integrin + CD47 unstimulated.
TABLE 2: FLIM analysis of total β2 integrin–CD47 interactions.
(Alcaide et al., 2012). Briefly, in vitro polarized WT and CD47−/− 
Th1 cells (5 × 105 in 100 μl) were suspended in Dulbecco’s 
phosphate-buffered saline (PBS) containing 0.1% (vol/vol) 
bovine serum albumin and 20 mM 4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid (HEPES), pH 7.4, and were drawn across 
WT or CD47−/− 4-h TNF-α–treated MHECs at 37°C in an in vitro 
flow chamber. Live-cell imaging of leukocyte TEM was per-
formed using a digital imaging system coupled to a Nikon 
Eclipse Ti inverted microscope (Nikon, Melville, NY) equipped 
with a 20×/0.75 NA differential interference contrast objective. 
Time-lapse videos were acquired using MetaMorph software 
(Molecular Devices, Sunnyvale, CA). Polarized Th1 cells also 
were drawn across immobilized ICAM-1-Fc (20 μg/ml), VCAM-
1-Fc (5 μg/ml), and E-selectin-Fc (20 μg/ml) chimeric proteins at 
estimated shear stress levels of 1.0, 0.75, and 0.5 dyn/cm2 as 
previously detailed (Alcaide et al., 2012). Live-cell imaging of 
leukocyte adhesion was recorded by a video camera coupled 
to a Nikon TE2000 inverted microscope equipped with a 
20×/0.75 NA phase contrast objective and VideoLab software 
(Mitov, Moorpark, CA).
Immunoprecipitation and blotting
CD47+ and CD47− Jurkat cells were solubi-
lized in cold lysis buffer (10 mM HEPES, pH 
7.4, 150 mM NaCl, 100 mM octylglucoside, 
1 mM phenylmethylsulfonyl fluoride, and 1× 
protease inhibitor cocktail [P8340; Sigma-
Aldrich, St. Louis, MO]) and centrifuged at 
100,000 × g for 30 min at 4°C. Lysates were 
divided and immunoprecipitated overnight 
at 4°C with protein A/G–Sepharose and 
mAb TS1/18, mAb 24, or mAb 24 and 1 mM 
Mn2+, and proteins were separated by SDS–
PAGE. The β2 integrin was detected by 
Western blot with goat anti-human β2 inte-
grin polyclonal antibody (R&D Systems, 
Minneapolis, MN).
Epifluorescence and time-correlated 
single-photon counting FLIM analysis
Aliquots of Jurkat CD47+ cells (3 × 105) were 
fixed in 4% parafor maldehyde and trans-
ferred to glass slides by Cytospin centrifuga-
tion (Shandon, Astmoor, England) and then 
FIGURE 7: CD47 and β2 integrin interact on the cellular membrane of Jurkat T-cells. 
(A) Representation of interacting fraction τm by pseudocolor images of the FLIM-FRET analysis 
of the interaction between β2 integrins with CD47 in unstimulated conditions and upon Mg2+/
EGTA activation, and the interaction between activated β2 integrin detected by mAb 24 and 
CD47 upon integrin activation with Mg2+/
EGTA. The color scale for τm ranges from 10 
to 3500 ps. The β2 integrin was identified 
with the donor fluorophore (Alexa Fluor 488) 
and CD47 with the acceptor fluorophore 
(Alexa Fluor 594). (B) Localization of β2 
integrin and CD47 by epifluorescence. Fixed 
cells were stained with (a, c) anti-β2 integrin 
polyclonal antibody alone (Quinn et al., 2001), 
(b, d) anti-β2 integrin antibody and anti-CD47 
(B6H12) antibody labeled with Alexa 594 
(unstimulated or with Mg2+/EGTA stimulation, 
respectively), (e) anti–activated-β2 integrin 
(mAb 24) alone upon Mg2+/EGTA stimulation, 
and (f) activated-β2 integrin (mAb 24) and 
anti-CD47 antibody also upon Mg2+/EGTA 
stimulation. Nucleus stained with DAPI.
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Condition τ1 (ps) a1 (%) τm (ps)
High-affinity 
β2 integrin 
(donor only) + 
Mg2+/EGTA
2905 ± 20 100 ± 0 2906 ± 20
High-affinity 
β2 integrin + 
CD47 (B6H12) 
+ Mg2+/EGTA
956 ± 70a 28 ± 1 2392 ± 40a
Values represent means ± SEM for n = 20 for each condition.
ap < 0.001 vs. β2 integrin donor only.
TABLE 3: FLIM analysis of high-affinity conformation of β2 integrin–
CD47 interactions.
blocked with 5% FBS in PBS at room temperature. A murine mAb to 
CD47 (B6H12) directly conjugated with Alexa 594 and a polyclonal 
Ab to β2 integrins were diluted in PBS–5% FBS and incubated over-
night at 4°C. As controls mAbs to PSGL-1 or αL integrin were used. 
Unlabeled primary Abs were detected using Alexa Fluor 488– or 
Alexa Fluor 594–conjugated secondary Abs when they corre-
sponded. Protein interactions were defined by time-correlated sin-
gle-photon counting FLIM as previously described (Mandal et al., 
2008; Bair et al., 2012). The fluorescence baseline lifetime of Alexa 
Fluor 488 (donor fluorophore, αL or β2 integrin) was calculated by 
single-exponential-decay fit ting of fluorescence emission in the ab-
sence of Alexa Fluor 594 (acceptor fluorophore). For samples stained 
for both donor and acceptor, lifetimes were fitted to a biexponential 
decay with lifetime of one component fixed to the donor-only life-
time. The lifetime for the interacting component, τ1, and the frac-
tional contributions for the percentage of interacting fluorophores, 
a1, were determined. Four or more separate experi ments were per-
formed, with n reported as total number of cells analyzed, and within 
each cell at least 10 different areas were used to determine the 
mean value. A Plan APO VC 60× oil DC N2 objective 1.4 NA, 
mounted on a Nikon Ti-E inverted microscope equipped with filter 
cubes used for DAPI, fluorescein isothiocyanate, and tetramethyl-
rhodamine isothiocyanate fluorophores (Nikon), was used for epif-
luorescence and FLIM as described (Mandal et al., 2008; Bair et al., 
2012). Nikon Elements 3.10 imaging software was used to collect 
epifluorescence data. For FLIM acquisition, Becker and Hickl (Berlin, 
Germany) a BDL-488-SMC Picosecond Diode Laser and both long-
pass (HQ500LP) and bandpass (HQ435/50) emission filters were 
used in combination with a hybrid detector (HPM-100-40 GaAsP 
hybrid detector) integrated with a Hamamatsu (Hamamatsu, Japan) 
R10467-40 hybrid photomultiplier tube. Becker and Hickl SPCM 
software with detector controller card was used to acquire FLIM 
data, and SPCImage 3.0 (Becker and Hickl, Berlin, Germany) soft-
ware was used for FLIM analysis.
Statistical analysis
Data are expressed as the mean ± SEM unless otherwise stated. 
Statistical analyses by Student’s t test or by analysis of variance 
followed by the Newman–Keuls test were performed with Prism 
software (GraphPad, La Jolla, CA) and considered statistically signifi-
cant at p < 0.05.
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 Supplemental Table S1.  FLIM analysis of αLintegrin/β2 integrin and β2 integrin/PSGL-1 
interactions. 
 
Condition τ1 (ps) a1 (%) τm(ps) 
αL integrin  (donor only) 2762±38 100±0 2613±49 
αL integrin – β2 integrin  334.6±38a 46±6 1617±113a 
β2 integrin (donor only) 2915±12 100±0 2888±10 
β2 integrin + PSGL-1 2233±99b 13±2 2894±11 
 
Values represent means ± SEM for n = 10 for each condition.  a P<0.001 vs αL integrin donor 
only. b P<0.001 vs β2 integrin donor only. 
Supplemental Figure S1. Human Jurkat CD47- (null) T cell adhesion to immobilized ICAM-1 
and VCAM-1 is reduced upon Mn
2+
 activation in an in vitro flow chamber model. Jurkat T cells 
were activated with Mn
2+
 (0.5 mM) for 15 min at 37
o
C and drawn across immobilized ICAM-1-
Fc (A) or VCAM-1-Fc (B) at various shear stress levels as described in Methods. Treatment of 
CD47- cells with Mn
2+
 did not restore binding comparable to CD47+ T cell adhesion. Data are  
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Supplemental Figure S2. b2 integrin interacts with aL integrin but not with PSGL-1 on the 
cellular membrane of Jurkat T cells. (A) Representation of interacting fraction tm by pseudocolor 
images of the FLIM-FRET analysis of the interaction between aL and b2 integrins and b2 
integrin and PSGL-1. The color scale for the tm lifetimes ranges from 10 to 3500 picoseconds 
(ps). As positive control aL integrin was identified with the donor fluorophore (Alexa Fluor 488) 
and b2 integrin with the acceptor fluorophore (Alexa Fluor 594). As a non-interacting control, b2 
integrin, was used as a donor and PSGL-1 as an acceptor. (B) Localization of b2 integrin, aL 
integrin and PSGL-1. Fixed cells were costained with (a) anti-aL integrin antibody alone (clone 
TS1/22) (b) anti-aL integrin antibody and anti-b2 integrin polyclonal antibody (Quinn et al., 
2001) followed by an anti-mouse Alexa Fluor 488-conjugated and anti-rabbit Alexa Fluor 594-
conjugated secondary antibodies, respectively. (c) anti-b2 integrin antibody alone and (d) anti-b2 
integrin antibody and anti-PSGL-1(clone 13A9) followed by an anti-rabbit Alexa Fluor 488-
conjugated and anti-mouseAlexa Fluor 594-conjugated secondary antibodies, respectively. The 
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Supplemental Figure S3. (A-D) Mean lifetime (tm) histograms of b2 integrin as the donor 
molecule: (A) with no acceptor (Donor only) in unstimulated conditions, (B) with CD47 (clone 
B6H12) as the acceptor molecule in unstimulated conditions, (C) donor only upon Mg
2+
/EGTA 
stimulation, (D) with CD47 as the acceptor molecule upon Mg
2+
/EGTA stimulation. (E,F) 
Activated b2 integrin as the donor molecule (E) without or (F) with CD47 as the acceptor 
molecule, respectively, upon Mg
2+
/EGTA stimulation. (G,H) Mean lifetime tm histograms of b2 
integrin as the donor molecule: (G) with no acceptor (Donor only), and (H) with PSGL-1 as the 
acceptor molecule. (I,J) aL integrin as the donor molecule: (I) with no acceptor (Donor only), 
and (J) with b2 integrin as the acceptor molecule. Histograms are representative of 20 different 
cells. 
